SIGN UP
LOG IN
S
SCPH
Scpharmaceutical
5.41
-0.11-1.99%After Hours: 5.43 +0.02 +0.37%18:54 08/05 EDT
OPEN/PREV CLOSE5.51/5.52
TODAY RANGE5.38-5.58
VOL201.47K
MARKET CAP285.60M
52 WEEK RANGE1.940-6.28
AVG VOL (3M)349.13K
% TURNOVER0.38%
TURNOVER--
P/E (TTM)-2.8291
% RANGE3.62%
EPS(TTM)-1.9123
P/E(FORWARD)-5.2524
P/B-53.0392
BVPS-0.1020
DIVIDEND--
P/S7.46
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP217.06M
SHARES OUTSTANDING52.79M
NEXT EARNINGS08/12-08/18
FREE FLOAT40.12M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·07/19 12:05
scPharmaceuticals Inc. (NASDAQ:SCPH) Soars 26% But It's A Story Of Risk Vs Reward
Simply Wall St·07/11 11:21
scPharmaceuticals (NASDAQ:SCPH) adds US$26m to market cap in the past 7 days, though investors from five years ago are still down 41%
Simply Wall St·06/02 18:50
Further Upside For scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Could Introduce Price Risks After 40% Bounce
Simply Wall St·05/27 10:02
Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable
Seeking Alpha·05/22 11:29
scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025
TipRanks·05/20 13:46
Maxim Group Keeps Their Buy Rating on scPharmaceuticals (SCPH)
TipRanks·05/17 17:38
Craig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)
Simply Wall St·05/16 10:24
Market Sentiment Around Loss-Making scPharmaceuticals Inc. (NASDAQ:SCPH)
TipRanks·05/16 00:58
scPharmaceuticals Earnings Call Highlights Growth and Expansion
TipRanks·05/15 04:06
scPharmaceuticals Reports Strong Q1 2025 Growth
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.